The power of drug samples
Executive Summary
Drug samples provided to doctors by brand firms are "probably the biggest thwart on improving generic fill rate," Excellus Blue Cross Blue Shield Chief Pharmacy Officer Joel Owerbach said at an April 9 briefing on generic drug utilization sponsored by the BCBS Association. Samples, which brand firms say can help reduce costs for needy patients and serve as emergency supplies during catastrophes, are becoming an increasing focus of detailing now that the PhRMA marketing code has limited the other items, such as pens or lunches, that firms can provide physicians (1"The Pink Sheet," March 30, 2009, p. 13)
You may also be interested in...
Coupon Redemption On The Rise: A Recession-Proof Boost For Scripts?
Coupon redemptions for prescription drugs more than doubled in 2008 compared to 2007, according to a telephone and internet study of 8,700 consumers conducted by Manhattan Research, a research division of Decision Resources
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.